NCT01795859
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
- Locations
-
- Teva Investigational Site 057 Birmingham, Alabama, United States
- Teva Investigational Site 038 Phoenix, Arizona, United States
- Teva Investigational Site 298 Fayetteville, Arkansas, United States
- Teva Investigational Site 050 Los Angeles, California, United States